Objective To screen the risk factors of acute kidney injury (AKI)in severe COVID-19 patients, construct a predictive model and explore its predictive value.
Methods From December 1,2022 to July 1, 2023, the relevant clinical data were retrospectively reviewed for 150 patients of severe COVID-19. Based upon the presence or absence of AKI, they were assigned into two groups of AKI(n=54)and non-AKI (n=96). Multivariate Logistic regression analysis was utilized for screening the risk factors for AKI in severe COVID-19 patients. A prediction model was constructed. And predictive value of model was verified by receiver operating characteristic curve(ROC).
Results Age was significantly lower in AKI group than that in non-AKI group74.50(63.00, 81.50) vs 75.00(70.00, 83.00) year. Proportion of AKI plus chronic obstructive pulmonary disease(1.85%)and proportion on high-flow nasal cannula(HFNC)(38.89%)were significantly lower than those in non-AKI group(13.54%, 58.33%) (both P<0.05). Scores of APACHE Ⅱ20.50(15.00, 25.00) and sequential organ failure assessment(SOFA)8.00(6.00, 10.00) were significantly higher in AKI group than those in non-AKI group16.00(13.00, 18.25), 5.00(4.00, 6.00). Proportion of patients with bacterial infection(61.11%) and receiving invasive ventilation therapy(57.41%)were significantly higher in AKI group than those in non-AKI group(40.62%, 25.00%) (both P<0.05). Oxygenation index109.55(75.99, 149.50)mmHg (1 mm Hg=0.133 kPa) and hemoglobin(109.61±24.46)g/L were significantly lower in AKI group than those in non-AKI group134.50(105.36, 156.57)mmHg and (121.24±21.77)g/L. N-terminal brain natriuretic peptide 3148.28(446.42, 13572.58)ng/L, procalcitonin1.48(0.56, 8.42)ng/L, partially activated thromboplastin time39.80(34.42, 45.32)second and aspartate aminotransferase38.00(21.00, 66.50)U/L were significantly higher in AKI group than those in non-AKI group502.41(171.50, 1703.00)ng/L, 370(110, 1040)ng/L, 36.95(32.70, 42.20)second, 34.00(20.50, 53.00)U/L. Blood urea nitrogen13.86(8.68, 18.70)mmol/L, serum creatinine177.00(90.30, 375.00)μmol/L and cystatin C2.67(1.77, 4.08)mg/L were significantly higher than those in non-AKI group7.31(5.51, 9.67)mmol/L, 62.95(51.75, 78.10)μmol/L and 1.34(1.10, 1.61)mg/L(all P<0.05). Multivariate Logistic regression analysis revealed that high SOFA score, concurrent bacterial infection and elevated serum creatinine were independent risk factors for AKI(all P<0.05). A prediction model was constructed with the above risk factors and ROC curve analysis performed. The results indicated that area under ROC curve(AUC) of model for predicting AKI was 0.916(95%CI:0.8687-0.9633) with a sensitivity of 77.36% and a specificity of 92.63%.
Conclusion Elevated serum creatinine, high SOFA score and concurrent bacterial infection are independent risk factors for severe COVID-19 AKI. The prediction model constructed by the above risk factors has some value in predicting the occurrence of AKI.